Related Experiment Video
Updated: Aug 11, 2026

Preparation of Acute Brain Slices Using an Optimized N-Methyl-D-glucamine Protective Recovery Method
Published on: February 26, 2018
Alpha-2 receptor blockade increases responsiveness of locus coeruleus neurons to excitatory stimulation
Abstract:
This study presents evidence that alpha 2-receptors in the locus coeruleus (LC) regulate the responsiveness of LC neurons to excitatory stimuli. In the first experiment, intravenous administration of the alpha 2-adrenergic antagonist idazoxan markedly potentiated the responses of LC neurons to the excitatory stimulus of contralateral hind paw compression (PC). Increased responsiveness of LC neurons to PC was seen with doses of idazoxan far below those that altered spontaneous activity of the LC. In the second experiment, increased responsiveness of LC neurons to PC was seen when low doses of idazoxan were infused directly into the LC, thereby indicating that increased responsiveness of LC neurons resulted from blockade of alpha 2-receptors in the LC region and not from greater stimulus input to the LC resulting from blockade of alpha 2-receptors elsewhere. In the third experiment, another alpha 2-adrenergic antagonist, yohimbine, also increased the responsiveness of LC neurons to PC. Finally, the response of the LC to another excitatory stimulus, peripheral injection of nicotine, was also found to be increased by idazoxan. Results obtained prior to these studies had indicated that alpha 2-receptors in the LC regulate the period of quiescence that follows a burst of LC firing. However, more recent studies suggest that this quiescence results primarily from changes in ionic conductance of the membrane following directly from depolarization. The present findings indicate that, in addition to whatever role alpha 2-receptors play in regulating postfiring quiescence, these receptors in the LC appear to play a major role in regulating the responsiveness of LC neurons to excitational influences.
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Adrenergic Antagonists: ɑ and β-Receptor Blockers

